Beacon Capital Management, Inc. Merck & Co., Inc. Transaction History

Beacon Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$84.53 - $94.96 $4,649 - $5,222	55 New	55 $5,000
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $1,650 - $1,831	-23 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$73.18 - $82.95 $1,683 - $1,907	23 New	23 $2,000
Q2 2020 Jul 16, 2020	SELL	$70.42 - $80.13 $2,605 - $2,964	-37 Closed	0 $0
Q1 2020 Apr 07, 2020	BUY	$63.36 - $87.82 $2,344 - $3,249	37 New	37 $3,000
Q3 2018 Oct 16, 2018	SELL	$57.69 - $67.84 $0 - $0	0 Closed	0 $0
Q2 2018 Jul 16, 2018	SELL	$50.83 - $59.72 $3,303 - $3,881	-65 Closed	0 $0
Q1 2018 Apr 04, 2018	BUY	$50.96 - $59.23 $2,598 - $3,020	51 Added 364.29%	65 $4,000
Q4 2017 Jan 11, 2018	BUY	$51.62 - $61.64 $722 - $862	14	14 $1,000

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Beacon Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Capital Management, Inc. with notifications on news.